Biopharmaceuticals
HIV/AIDS
News Release - July 14, 2006
Conjuchem announces clinical hold of its DAC(TM):GRF Program in HIV Lipodystrophy
Source: Conjuchem Biotechnologies
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.